These results demonstrated that BRAF regulate CD70 expression independently of the V600E mutation and confirm that MAPK pathway activation positively regulates melanoma-expressed CD70 and that inhibition of this pathway at BRAF or MEK level are both able to reduce melanoma expressed CD70. The gene discussed is BRAF; the disease is melanoma.